- Home
- CVAC vs FSLY Comparison
CVAC vs FSLY Comparison
Compare CVAC & FSLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- FSLY
- Stock Information
- Founded
- CVAC 2000
- FSLY 2011
- Country
- CVAC Germany
- FSLY United States
- Employees
- CVAC N/A
- FSLY N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- FSLY Computer Software: Prepackaged Software
- Sector
- CVAC Health Care
- FSLY Technology
- Exchange
- CVAC Nasdaq
- FSLY Nasdaq
- Market Cap
- CVAC 1.2B
- FSLY 1.1B
- IPO Year
- CVAC 2020
- FSLY 2019
- Fundamental
- Price
- CVAC $5.35
- FSLY $8.40
- Analyst Decision
- CVAC Hold
- FSLY Hold
- Analyst Count
- CVAC 3
- FSLY 10
- Target Price
- CVAC $6.83
- FSLY $8.44
- AVG Volume (30 Days)
- CVAC 471.1K
- FSLY 2.8M
- Earning Date
- CVAC 11-11-2025
- FSLY 11-05-2025
- Dividend Yield
- CVAC N/A
- FSLY N/A
- EPS Growth
- CVAC N/A
- FSLY N/A
- EPS
- CVAC 1.01
- FSLY N/A
- Revenue
- CVAC $599,540,810.00
- FSLY $570,968,000.00
- Revenue This Year
- CVAC N/A
- FSLY $12.21
- Revenue Next Year
- CVAC $23.95
- FSLY $6.92
- P/E Ratio
- CVAC $5.32
- FSLY N/A
- Revenue Growth
- CVAC 675.15
- FSLY 7.43
- 52 Week Low
- CVAC $2.37
- FSLY $4.65
- 52 Week High
- CVAC $5.72
- FSLY $12.08
- Technical
- Relative Strength Index (RSI)
- CVAC 44.43
- FSLY 62.72
- Support Level
- CVAC $5.32
- FSLY $7.29
- Resistance Level
- CVAC $5.41
- FSLY $9.10
- Average True Range (ATR)
- CVAC 0.04
- FSLY 0.38
- MACD
- CVAC -0.01
- FSLY 0.10
- Stochastic Oscillator
- CVAC 33.33
- FSLY 65.93
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About FSLY Fastly Inc.
Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focus on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly is in far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated nearly three fourths of its revenue in the United States in 2024.